CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
November 17, 2023 at 08:44 AM EST
The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.
